Beneficial role of telmisartan on cardiovascular complications associated with STZ-induced type 2 diabetes in rats.
We studied the effect of an eight-week treatment with telmisartan (5 mg kg(-1)day(-1)) on cardiovascular complications that are associated with type 2 diabetes in a neonatal rat model. Type 2 diabetes was induced by the administration of 90 mg/kg streptoz..... Read More